Holdings of Goldman Sachs Future Health Care Equity ETF
Goldman Sachs ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 22.6M $ including 22.3M $ in equities, 98.8 %
- Positions
- 39 in 8 countries
- Top ten
- 58.5 % of net assets
- Filed on
- Feb 28, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 2,619 | 2.8M $ | 12.19 % |
| 2 | Johnson & Johnson | 7,357 | 1.8M $ | 8.09 % |
| 3 | AstraZeneca PLC | 6,923 | 1.4M $ | 6.40 % |
| 4 | Merck & Co Inc | 10,915 | 1.4M $ | 5.98 % |
| 5 | Boston Scientific Corp | 17,062 | 1.3M $ | 5.80 % |
| 6 | Thermo Fisher Scientific Inc | 2,001 | 1M $ | 4.61 % |
| 7 | Intuitive Surgical Inc | 2,003 | 1M $ | 4.46 % |
| 8 | Guardant Health Inc | 8,978 | 843K $ | 3.73 % |
| 9 | Hoya Corp | 4,523 | 818.8K $ | 3.62 % |
| 10 | Argenx SE | 1,061 | 813.7K $ | 3.60 % |
| 11 | Cencora Inc | 2,056 | 765.1K $ | 3.38 % |
| 12 | Abbott Laboratories | 6,078 | 707.2K $ | 3.13 % |
| 13 | Lonza Group AG | 953 | 664.5K $ | 2.94 % |
| 14 | Agilent Technologies Inc | 5,409 | 656.5K $ | 2.90 % |
| 15 | Dexcom Inc | 8,247 | 605.6K $ | 2.68 % |
| 16 | Roivant Sciences Ltd | 17,375 | 502.8K $ | 2.22 % |
| 17 | Mettler-Toledo International Inc | 293 | 400.4K $ | 1.77 % |
| 18 | Apogee Therapeutics Inc | 5,225 | 365.8K $ | 1.62 % |
| 19 | Sartorius Stedim Biotech | 1,658 | 358.4K $ | 1.59 % |
| 20 | Ionis Pharmaceuticals Inc | 3,918 | 317.9K $ | 1.41 % |
| 21 | QIAGEN NV | 6,309 | 314.2K $ | 1.39 % |
| 22 | Repligen Corp | 2,204 | 283.7K $ | 1.26 % |
| 23 | Insmed Inc | 1,846 | 275.7K $ | 1.22 % |
| 24 | Penumbra Inc | 750 | 258.3K $ | 1.14 % |
| 25 | Natera Inc | 1,137 | 236.5K $ | 1.05 % |
| 26 | Xenon Pharmaceuticals Inc | 5,393 | 233.1K $ | 1.03 % |
| 27 | Royalty Pharma PLC | 4,939 | 228.2K $ | 1.01 % |
| 28 | UnitedHealth Group Inc | 775 | 227.3K $ | 1.01 % |
| 29 | Cytokinetics Inc | 3,546 | 220.6K $ | 0.98 % |
| 30 | Bridgebio Pharma Inc | 3,115 | 207.1K $ | 0.92 % |
| 31 | Madrigal Pharmaceuticals Inc | 466 | 201.3K $ | 0.89 % |
| 32 | Rhythm Pharmaceuticals Inc | 2,150 | 199.4K $ | 0.88 % |
| 33 | CG oncology Inc | 3,187 | 187.4K $ | 0.83 % |
| 34 | Arcellx Inc | 1,623 | 184.7K $ | 0.82 % |
| 35 | GeneDx Holdings Corp | 1,664 | 132.6K $ | 0.59 % |
| 36 | Revolution Medicines Inc | 1,159 | 118.2K $ | 0.52 % |
| 37 | Insulet Corp | 432 | 106.5K $ | 0.47 % |
| 38 | Ultragenyx Pharmaceutical Inc | 3,619 | 84.6K $ | 0.37 % |
| 39 | Structure Therapeutics Inc | 1,092 | 68.8K $ | 0.30 % |
Sector breakdown
- Health care 74.2 %
- Unattributed 25.8 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 85.3 %
- GBP 6.5 %
- JPY 3.7 %
- CHF 3.0 %
- EUR 1.6 %
The quoted currency of each line, as declared.
Country breakdown
- United States 78.3 %
- United Kingdom 6.5 %
- Japan 3.7 %
- Netherlands 3.6 %
- Switzerland 3.0 %
- Bermuda 2.3 %
- France 1.6 %
- Canada 1.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 32 | 17.5M $ | 78.34 % |
| 2 | United Kingdom | 1 | 1.4M $ | 6.48 % |
| 3 | Japan | 1 | 818.8K $ | 3.67 % |
| 4 | Netherlands | 1 | 813.7K $ | 3.64 % |
| 5 | Switzerland | 1 | 664.5K $ | 2.98 % |
| 6 | Bermuda | 1 | 502.8K $ | 2.25 % |
| 7 | France | 1 | 358.4K $ | 1.61 % |
| 8 | Canada | 1 | 233.1K $ | 1.04 % |
Cite this page
Titelia. "Holdings of Goldman Sachs Future Health Care Equity ETF". https://titelia.com/en/funds/S000072296